A global biopharmaceutical company with fully integrated research, manufacturing and commercialization capabilities, Biominhai develops and transfers vaccines for infectious diseases and is the leading manufacturer of hepatitis B vaccine in China. The company has 9 marketed products, including 2 COVID-19 vaccines approved for emergency use, supported by 12 in-house R&D platforms.
댓글이 없습니다.
평가 & 댓글 남기기